Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-025892
Filing Date
2014-07-02
Accepted
2014-07-02 16:43:23
Documents
1
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - RICHARD LERNER, M.D. rrd412600.html 4  
1 FORM 4 - RICHARD LERNER, M.D. rrd412600.xml 4 6062
  Complete submission text file 0001181431-14-025892.txt   7525
Mailing Address THE SCRIPPS RESEARCH INSTITUTE 10550 N. TORREY PINES ROAD LA JOLLA CA 92037
Business Address
LERNER RICHARD A (Reporting) CIK: 0001316274 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 14957104

Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations